EDSA Edesa Biotech Inc

Price (delayed)

$4.32

Market cap

$13.89M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$2.37

Enterprise value

$11.15M

Edesa Biotech, Inc. is a clinical-stage biopharmaceutical company focused on developing innovative treatments for inflammatory and immune-related diseases with clear unmet medical needs. The company's two lead product candidates, EB05 ...

Highlights
Edesa Biotech's EPS has soared by 56% YoY and by 9% from the previous quarter
EDSA's debt has dropped by 55% year-on-year and by 26% since the previous quarter
The quick ratio has shrunk by 62% YoY and by 28% QoQ
The equity has dropped by 52% year-on-year and by 26% since the previous quarter

Key stats

What are the main financial stats of EDSA
Market
Shares outstanding
3.22M
Market cap
$13.89M
Enterprise value
$11.15M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
3.17
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Earnings
Revenue
$0
EBIT
-$7.24M
EBITDA
-$7.02M
Free cash flow
-$6.34M
Per share
EPS
-$2.37
Free cash flow per share
-$1.99
Book value per share
$1.36
Revenue per share
$0
TBVPS
$1.36
Balance sheet
Total assets
$6.48M
Total liabilities
$2.15M
Debt
$58,143
Equity
$4.32M
Working capital
$2.09M
Liquidity
Debt to equity
0.01
Current ratio
1.97
Quick ratio
1.82
Net debt/EBITDA
0.39
Margins
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Efficiency
Return on assets
-88.9%
Return on equity
-115.6%
Return on invested capital
N/A
Return on capital employed
-167.5%
Return on sales
N/A
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

EDSA stock price

How has the Edesa Biotech stock price performed over time
Intraday
1.65%
1 week
-1.59%
1 month
-3.36%
1 year
-24.51%
YTD
-5.47%
QTD
0.47%

Financial performance

How have Edesa Biotech's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$8.51M
Net income
-$7.25M
Gross margin
N/A
Net margin
N/A
EDSA's net income is up by 45% year-on-year and by 6% since the previous quarter
Edesa Biotech's operating income has increased by 37% YoY and by 2.2% from the previous quarter

Growth

What is Edesa Biotech's growth rate over time

Valuation

What is Edesa Biotech stock price valuation
P/E
N/A
P/B
3.17
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Edesa Biotech's EPS has soared by 56% YoY and by 9% from the previous quarter
The equity has dropped by 52% year-on-year and by 26% since the previous quarter
EDSA's price to book (P/B) is 32% higher than its last 4 quarters average of 2.4 but 31% lower than its 5-year quarterly average of 4.6

Efficiency

How efficient is Edesa Biotech business performance
Edesa Biotech's return on assets has increased by 14% YoY but it has decreased by 6% QoQ
The company's return on equity rose by 12% YoY but it fell by 11% QoQ

Dividends

What is EDSA's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for EDSA.

Financial health

How did Edesa Biotech financials performed over time
EDSA's current ratio has shrunk by 62% YoY and by 28% QoQ
The quick ratio has shrunk by 62% YoY and by 28% QoQ
EDSA's debt is 99% smaller than its equity
EDSA's debt has dropped by 55% year-on-year and by 26% since the previous quarter
The equity has dropped by 52% year-on-year and by 26% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.